The ReWalk exoskeleton system is set to be tested in a 160-person, four-year long, multi-center study by the U.S. Department of Veterans Affairs to evaluate the impact of exoskeleton use in a home or daily life setting.
A study on the benefits of the ReWalk Robotics exoskeleton found significant improvements in the quality of life for an individual with spinal cord injury using the system.
U.S. veterans with spinal cord injuries will now have access to ReWalk Robotics' exoskeleton systems, following a decision by the U.S. Department of Veterans Affairs.
Exoskeleton maker ReWalk Robotics saw third-quarter revenue climb substantially from the second quarter, although revenue was still down from the same quarter in the previous year.
The founder of ReWalk Robotics, whose U.S. headquarters is in Marlborough, will retire in November and not seek re-election to the board of directors, the company announced.
Dr. Amit Goffer will step down as president and chief technology officer of the company, which produces exoskeletons to help those with spinal cord injuries walk again. His resignation will take effect Nov. 18. Goffer founded ReWalk in 20001, following an accident that left him a quadriplegic. He pioneered the invention and development of the ReWalk Robotics wearable exoskeleton, enabling individuals with lower-limb paralysis to walk again.
Despite a slower than expected quarter, ReWalk Robotics of Marlborough saw a revenue jump of more than 20 percent, but declared a $5.8 million loss as the manufacturer of robotic exoskeletons for spinal cord-injury victims seeks more customers.
ReWalk Robotics, the first company to bring an exoskeleton to market after approval from the U.S. Food and Drug Administration, is celebrating a commercialization milestone that hits close to home today.
ReWalk Robotics, the Marlborough-based maker of exoskeleton systems for paraplegics, released the sixth-generation version of its exoskeleton this week.